1
|
Pan Y, Liu T, Wang X, Sun J. Research progress of coumarins and their derivatives in the treatment of diabetes. J Enzyme Inhib Med Chem 2022; 37:616-628. [PMID: 35067136 PMCID: PMC8788346 DOI: 10.1080/14756366.2021.2024526] [Citation(s) in RCA: 14] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023] Open
Abstract
Diabetes is a group of metabolic diseases characterised by chronic hyperglycaemia caused by multiple causes, which is caused by insulin secretion and/or utilisation defects. It is characterised by increased fasting and postprandial blood glucose levels due to insulin deficiency or insulin resistance. It is reported that the harm of diabetes mainly comes from its complications, and the cardiovascular disease caused by diabetes is the primary cause of its harm. China has the largest number of diabetic patients in the world, and the prevention and control of diabetes are facing great challenges. In recent years, many kinds of literature have been published abroad, which have proved that coumarin and its derivatives are effective in the treatment of diabetic complications such as nephropathy and cardiovascular disease. In this paper, the types of antidiabetic drugs and the anti-diabetic mechanism of coumarins were reviewed.
Collapse
Affiliation(s)
- Yinbo Pan
- School of Pharmacy and Pharmaceutical Sciences, Shandong First Medical University, Jinan, Shandong, China
- Institute of Materia Medica, Shandong Academy of Medical Sciences, Jinan, Shandong, China
| | - Teng Liu
- School of Pharmacy and Pharmaceutical Sciences, Shandong First Medical University, Jinan, Shandong, China
- Institute of Materia Medica, Shandong Academy of Medical Sciences, Jinan, Shandong, China
| | - Xiaojing Wang
- School of Pharmacy and Pharmaceutical Sciences, Shandong First Medical University, Jinan, Shandong, China
- Institute of Materia Medica, Shandong Academy of Medical Sciences, Jinan, Shandong, China
| | - Jie Sun
- School of Pharmacy and Pharmaceutical Sciences, Shandong First Medical University, Jinan, Shandong, China
- Institute of Materia Medica, Shandong Academy of Medical Sciences, Jinan, Shandong, China
| |
Collapse
|
2
|
Sun Y, Yanming G, Jinxin L, Lamei X, Fan M, Qian H, Li Y, Wang L. Hydroxysafflor Yellow A - An Important Natural Pigment for Treating Metabolic Diseases. FOOD REVIEWS INTERNATIONAL 2021. [DOI: 10.1080/87559129.2021.2013256] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Affiliation(s)
- Yujie Sun
- School of Food Science and Technology, State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, China
| | - Guan Yanming
- China National Research Institute of Food and Fermentation Industries Co. Ltd, Beijing, China
| | - Liu Jinxin
- School of Food Science and Technology, State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, China
| | - Xue Lamei
- School of Food Science and Technology, State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, China
| | - Mingcong Fan
- School of Food Science and Technology, State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, China
| | - Haifeng Qian
- School of Food Science and Technology, State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, China
| | - Yan Li
- School of Food Science and Technology, State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, China
| | - Li Wang
- School of Food Science and Technology, State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, China
| |
Collapse
|
3
|
Xue X, Deng Y, Wang J, Zhou M, Liao L, Wang C, Peng C, Li Y. Hydroxysafflor yellow A, a natural compound from Carthamus tinctorius L with good effect of alleviating atherosclerosis. PHYTOMEDICINE : INTERNATIONAL JOURNAL OF PHYTOTHERAPY AND PHYTOPHARMACOLOGY 2021; 91:153694. [PMID: 34403879 DOI: 10.1016/j.phymed.2021.153694] [Citation(s) in RCA: 34] [Impact Index Per Article: 11.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/17/2021] [Revised: 07/23/2021] [Accepted: 07/28/2021] [Indexed: 06/13/2023]
Abstract
BACKGROUND Atherosclerosis is a chronic vascular inflammatory disease with complex pathogenesis. Its serious consequence is insufficient blood supply to heart and brain, which eventually leads to myocardial ischemia, infarction and stroke. Hydroxysafflor yellow A (HSYA), a single chalcone glycoside compound with a variety of pharmacological effects, which has shown a potential biological activity for prevention and treatment of atherosclerosis. PURPOSE The main purpose of this review is to comprehensively elucidate the mechanism of HSYA on atherosclerosis and its risk factors (hyperlipidemia, hypertension and diabetes mellitus). METHOD The literatures on HSYA in the treatment of atherosclerosis and its risk factors were searched in PubMed, Google Scholar, China National Knowledge Infrastructure, including in vitro (cell), in vivo (animal) and clinical (human) studies, and summarized reasonably. RESULTS HSYA is a promising natural product for treating atherosclerosis. It can suppress foam cell formation, vascular endothelial cell dysfunction, vascular smooth muscle cell proliferation and migration, and platelet activation. The mechanisms are achieved by regulating the reverse cholesterol transport process, fatty acid synthesis, oxidative stress, PI3K/Akt/mTOR, NLRP3 inflammasome, TNFR1/NF-κB, NO-cGMP, Bax/Bcl-2, MAPKs, CDK/CyclinD and TLR4/Rac1/Akt signaling pathways. Besides, HSYA is devoted to lowering blood lipids, regulating ion channels, reducing vascular inflammation, and protecting pancreatic beta cells, which is conducive to reducing the harm of independent risk factors of atherosclerosis. CONCLUSIONS HSYA exhibits the preventive and therapeutic effects on atherosclerosis and its risk factors in vivo and in vitro, which is relevant to multiple mechanisms. The clinical trials of HSYA need to be further investigated to provide a solid foundation for its clinical application.
Collapse
Affiliation(s)
- Xinyan Xue
- State Key Laboratory of Southwestern Chinese Medicine Resources, Key Laboratory of Standardization for Chinese Herbal Medicine, Ministry of Education, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
| | - Ying Deng
- State Key Laboratory of Southwestern Chinese Medicine Resources, Key Laboratory of Standardization for Chinese Herbal Medicine, Ministry of Education, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
| | - Jing Wang
- State Key Laboratory of Southwestern Chinese Medicine Resources, Key Laboratory of Standardization for Chinese Herbal Medicine, Ministry of Education, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
| | - Mengting Zhou
- State Key Laboratory of Southwestern Chinese Medicine Resources, Key Laboratory of Standardization for Chinese Herbal Medicine, Ministry of Education, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
| | - Li Liao
- State Key Laboratory of Southwestern Chinese Medicine Resources, Key Laboratory of Standardization for Chinese Herbal Medicine, Ministry of Education, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
| | - Cheng Wang
- State Key Laboratory of Southwestern Chinese Medicine Resources, Key Laboratory of Standardization for Chinese Herbal Medicine, Ministry of Education, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
| | - Cheng Peng
- State Key Laboratory of Southwestern Chinese Medicine Resources, Key Laboratory of Standardization for Chinese Herbal Medicine, Ministry of Education, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
| | - Yunxia Li
- State Key Laboratory of Southwestern Chinese Medicine Resources, Key Laboratory of Standardization for Chinese Herbal Medicine, Ministry of Education, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
| |
Collapse
|
4
|
Attenuation of methylglyoxal-induced glycation and cellular dysfunction in wound healing by Centella cordifolia. Saudi J Biol Sci 2021; 28:813-824. [PMID: 33424371 DOI: 10.1016/j.sjbs.2020.11.016] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2020] [Revised: 10/25/2020] [Accepted: 11/01/2020] [Indexed: 01/13/2023] Open
Abstract
Current pre-clinical evidences of Centella focus on its pharmacological effects on normal wound healing but there are limited studies on the bioactivity of Centella in cellular dysfunction associated with diabetic wounds. Hence we planned to examine the potential of Centella cordifolia in inhibiting methylglyoxal (MGO)-induced extracellular matrix (ECM) glycation and promoting the related cellular functions. A Cell-ECM adhesion assay examined the ECM glycation induced by MGO. Different cell types that contribute to the healing process (fibroblasts, keratinocytes and endothelial cells) were evaluated for their ability to adhere to the glycated ECM. Methanolic extract of Centella species was prepared and partitioned to yield different solvent fractions which were further analysed by high performance liquid chromatography equipped with photodiode array detector (HPLC-PDA) method. Based on the antioxidant [2,2-diphenyl-1-picrylhydrazyl (DPPH) assay] screening, anti-glycation activity and total phenolic content (TPC) of the different Centella species and fractions, the ethyl acetate fraction of C. cordifolia was selected for further investigating its ability to inhibit MGO-induced ECM glycation and promote cellular distribution and adhesion. Out of the three Centella species (C. asiatica, C. cordifolia and C. erecta), the methanolic extract of C. cordifolia showed maximum inhibition of Advanced glycation end products (AGE) fluorescence (20.20 ± 4.69 %, 25.00 ± 3.58 % and 16.18 ± 1.40 %, respectively). Its ethyl acetate fraction was enriched with phenolic compounds (3.91 ± 0.12 mg CAE/μg fraction) and showed strong antioxidant (59.95 ± 7.18 μM TE/μg fraction) and antiglycation activities. Improvement of cells spreading and adhesion of endothelial cells, fibroblasts and keratinocytes was observed for ethyl acetate treated MGO-glycated extracellular matrix. Significant reduction in attachment capacity of EA.hy926 cells seeded on MGO-glycated fibronectin (41.2%) and attachment reduction of NIH3t3 and HaCaT cells seeded on MGO-glycated collagen (33.7% and 24.1%, respectively) were observed. Our findings demonstrate that ethyl acetate fraction of C. cordifolia was effective in attenuating MGO-induced glycation and cellular dysfunction in the in-vitro wound healing models suggesting that C. cordifolia could be a potential candidate for diabetic wound healing. It could be subjected for further isolation of new phytoconstituents having potential diabetic wound healing properties.
Collapse
Key Words
- AGA, minoguanidine hydrochloride
- AGEs, Advanced glycation end products
- AlCl3, Aluminum chloride
- Antiglycation
- BSA, Bovine serum albumin
- Centella
- DMEM, Dulbecco's Modified Eagle Medium
- DPPH, 2,2-diphenyl-1-picrylhydrazyl
- Diabetic complications
- EA, Ethyl acetate fraction
- ECM, Extracellular matrix
- FN, Fibronectin
- HEPES, Hydroxyethyl piperazineethanesulfonic acid
- HPLC-PDA
- HPLC-PDA, High performance liquid chromatography equipped with photodiode array detector
- HbA1c, Hemoglobin A1c
- MGO, Methylglyoxal
- Methylglyoxal
- NaNO2, Sodium nitrite
- NaOH, Sodium hydroxide
- PBS, Phosphate buffered saline
- RAGE, Receptor for advanced glycation endproducts
- ROS, Reactive oxygen species
- SDS-PAGE, Sodium dodecyl sulphate-polyacrylamide gel electrophoresis
- TLC, Thin-layer chromatography
- TNBSA, 2,4,6-trinitrobenzene sulfonic acid
- TNBSA, Trinitrobenzene sulfonic acid
- TPC, Total phenolic content
- Trolox, 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid
- Wounds
Collapse
|
5
|
Hu Y, Wang B, Yang J, Liu T, Sun J, Wang X. Synthesis and biological evaluation of 3-arylcoumarin derivatives as potential anti-diabetic agents. J Enzyme Inhib Med Chem 2018; 34:15-30. [PMID: 30362362 PMCID: PMC6211316 DOI: 10.1080/14756366.2018.1518958] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022] Open
Abstract
A variety of substituted 3-arylcoumarin derivatives were synthesised through microwave radiation heating. The method has characteristics of environmental friendliness, economy, simple separation, and purification process, less by-products and high reaction yield. Those 3-arylcoumarin derivatives were screened for antioxidant, α-glucosidase inhibitory and advanced glycation end-products (AGEs) formation inhibitory. Most compounds exhibited significant antioxidant and AGEs formation inhibitory activities. Anti-diabetic activity studies showed that compounds 11 and 17 were equipotent to the standard drug glibenclamide in vivo. According to the experimental results, the target compound 35 can be used as a lead compound for the development of new anti-diabetic drugs. The whole experiment showed that anti-diabetic activity is prevalent in 3-arylcoumarins, which added a new natural skeleton to the development of anti-diabetic active drugs.
Collapse
Affiliation(s)
- Yuheng Hu
- a School of Medicine and Life Sciences , University of Jinan-Shandong Academy of Medical Sciences , Jinan , Shandong , China.,b Institute of MateriaMedica , Shandong Academy of Medical Sciences , Jinan , Shandong , China.,c Key Laboratory for Biotech-Drugs Ministry of Health , Jinan , Shandong , China.,d Key Laboratory for Rare & Uncommon Diseases of Shandong Province , Jinan , Shandong , China
| | - Bing Wang
- a School of Medicine and Life Sciences , University of Jinan-Shandong Academy of Medical Sciences , Jinan , Shandong , China.,b Institute of MateriaMedica , Shandong Academy of Medical Sciences , Jinan , Shandong , China.,c Key Laboratory for Biotech-Drugs Ministry of Health , Jinan , Shandong , China.,d Key Laboratory for Rare & Uncommon Diseases of Shandong Province , Jinan , Shandong , China
| | - Jie Yang
- a School of Medicine and Life Sciences , University of Jinan-Shandong Academy of Medical Sciences , Jinan , Shandong , China.,b Institute of MateriaMedica , Shandong Academy of Medical Sciences , Jinan , Shandong , China.,c Key Laboratory for Biotech-Drugs Ministry of Health , Jinan , Shandong , China.,d Key Laboratory for Rare & Uncommon Diseases of Shandong Province , Jinan , Shandong , China
| | - Teng Liu
- a School of Medicine and Life Sciences , University of Jinan-Shandong Academy of Medical Sciences , Jinan , Shandong , China.,b Institute of MateriaMedica , Shandong Academy of Medical Sciences , Jinan , Shandong , China.,c Key Laboratory for Biotech-Drugs Ministry of Health , Jinan , Shandong , China.,d Key Laboratory for Rare & Uncommon Diseases of Shandong Province , Jinan , Shandong , China
| | - Jie Sun
- a School of Medicine and Life Sciences , University of Jinan-Shandong Academy of Medical Sciences , Jinan , Shandong , China.,b Institute of MateriaMedica , Shandong Academy of Medical Sciences , Jinan , Shandong , China.,c Key Laboratory for Biotech-Drugs Ministry of Health , Jinan , Shandong , China.,d Key Laboratory for Rare & Uncommon Diseases of Shandong Province , Jinan , Shandong , China
| | - Xiaojing Wang
- a School of Medicine and Life Sciences , University of Jinan-Shandong Academy of Medical Sciences , Jinan , Shandong , China.,b Institute of MateriaMedica , Shandong Academy of Medical Sciences , Jinan , Shandong , China.,c Key Laboratory for Biotech-Drugs Ministry of Health , Jinan , Shandong , China.,d Key Laboratory for Rare & Uncommon Diseases of Shandong Province , Jinan , Shandong , China
| |
Collapse
|
6
|
Hydroxysafflor Yellow A: A Promising Therapeutic Agent for a Broad Spectrum of Diseases. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE 2018; 2018:8259280. [PMID: 30356354 PMCID: PMC6176289 DOI: 10.1155/2018/8259280] [Citation(s) in RCA: 53] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/09/2018] [Accepted: 08/12/2018] [Indexed: 01/13/2023]
Abstract
Hydroxysafflor yellow A (HSYA) is one of the major bioactive and water-soluble compounds isolated from Carthami Flos, the flower of safflower (Carthamus tinctorius L.). As a natural pigment with favorable medical use, HSYA has gained extensive attention due to broad and effective pharmacological activities since first isolation in 1993. In clinic, the safflor yellow injection which mainly contains about 80% HSYA was approved by the China State Food and Drug Administration and used to treat cardiac diseases such as angina pectoris. In basic pharmacology, HSYA has been proved to exhibit a broad spectrum of biological effects that include, but not limited to, cardiovascular effect, neuroprotection, liver and lung protection, antitumor activity, metabolism regulation, and endothelium cell protection. Although a great number of studies have been carried out to prove the pharmacological effects and corresponding mechanisms of HYSA, a systemic review of HYSA has not yet been seen. Here, we provide a comprehensive summarization of the pharmacological effects of HYSA. Together with special attention to mechanisms of actions, this review can serve as the basis for further researches and developments of this medicinal compound.
Collapse
|
7
|
Wang B, Liu T, Wu Z, Zhang L, Sun J, Wang X. Synthesis and biological evaluation of stilbene derivatives coupled to NO donors as potential antidiabetic agents. J Enzyme Inhib Med Chem 2018; 33:416-423. [PMID: 29374975 PMCID: PMC7011920 DOI: 10.1080/14756366.2018.1425686] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023] Open
Abstract
The work is focused on the design of drugs that prevent and treat diabetes and its complications. A novel class of stilbene derivatives were prepared by coupling NO donors of alkyl nitrate and were fully characterised by NMR and other techniques. These compounds were tested in vitro activity, including α-glucosidase inhibitory activity, aldose reductase (AR) inhibitory activity and advanced glycation end products (AGEs) formation inhibitory activity. A class of modified compounds could play a significant effect for treatment of diabetic complications. Target compounds 3e and 7c offered a potential drug design concept for the development of therapeutic or preventive agents for diabetes and its complications.
Collapse
Affiliation(s)
- Bing Wang
- a School of Medicine and Life Sciences , University of Jinan-Shandong Academy of Medical Sciences , Jinan , China.,b Institute of Materia Medica, Shandong Academy of Medical Sciences , Jinan , China.,c Key Laboratory for Biotech-Drugs Ministry of Health , Jinan , China.,d Key Laboratory for Rare & Uncommon Diseases of Shandong Province , Jinan , China
| | - Teng Liu
- a School of Medicine and Life Sciences , University of Jinan-Shandong Academy of Medical Sciences , Jinan , China.,b Institute of Materia Medica, Shandong Academy of Medical Sciences , Jinan , China.,c Key Laboratory for Biotech-Drugs Ministry of Health , Jinan , China.,d Key Laboratory for Rare & Uncommon Diseases of Shandong Province , Jinan , China
| | - Zhongyu Wu
- a School of Medicine and Life Sciences , University of Jinan-Shandong Academy of Medical Sciences , Jinan , China.,b Institute of Materia Medica, Shandong Academy of Medical Sciences , Jinan , China.,c Key Laboratory for Biotech-Drugs Ministry of Health , Jinan , China.,d Key Laboratory for Rare & Uncommon Diseases of Shandong Province , Jinan , China
| | - Lei Zhang
- a School of Medicine and Life Sciences , University of Jinan-Shandong Academy of Medical Sciences , Jinan , China.,b Institute of Materia Medica, Shandong Academy of Medical Sciences , Jinan , China.,c Key Laboratory for Biotech-Drugs Ministry of Health , Jinan , China.,d Key Laboratory for Rare & Uncommon Diseases of Shandong Province , Jinan , China
| | - Jie Sun
- a School of Medicine and Life Sciences , University of Jinan-Shandong Academy of Medical Sciences , Jinan , China.,b Institute of Materia Medica, Shandong Academy of Medical Sciences , Jinan , China.,c Key Laboratory for Biotech-Drugs Ministry of Health , Jinan , China.,d Key Laboratory for Rare & Uncommon Diseases of Shandong Province , Jinan , China
| | - Xiaojing Wang
- a School of Medicine and Life Sciences , University of Jinan-Shandong Academy of Medical Sciences , Jinan , China.,b Institute of Materia Medica, Shandong Academy of Medical Sciences , Jinan , China.,c Key Laboratory for Biotech-Drugs Ministry of Health , Jinan , China.,d Key Laboratory for Rare & Uncommon Diseases of Shandong Province , Jinan , China
| |
Collapse
|
8
|
Wang B, Li N, Liu T, Sun J, Wang X. Synthesis and biological evaluation of novel neoflavonoid derivatives as potential antidiabetic agents. RSC Adv 2017. [DOI: 10.1039/c7ra06457h] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022] Open
Abstract
Various substituted neoflavonoid derivatives were synthesized. These neoflavonoid derivatives were screened for antioxidant, a-glucosidase inhibitory, ALR2 inhibitory and advanced glycation end-product formation inhibitory activities.
Collapse
Affiliation(s)
- Bing Wang
- School of Medicine and Life Sciences
- University of Jinan
- Shandong Academy of Medical Sciences
- Jinan 250200
- China
| | - Na Li
- School of Medicine and Life Sciences
- University of Jinan
- Shandong Academy of Medical Sciences
- Jinan 250200
- China
| | - Teng Liu
- School of Medicine and Life Sciences
- University of Jinan
- Shandong Academy of Medical Sciences
- Jinan 250200
- China
| | - Jie Sun
- School of Medicine and Life Sciences
- University of Jinan
- Shandong Academy of Medical Sciences
- Jinan 250200
- China
| | - Xiaojing Wang
- School of Medicine and Life Sciences
- University of Jinan
- Shandong Academy of Medical Sciences
- Jinan 250200
- China
| |
Collapse
|
9
|
Ferulic acid prevents methylglyoxal-induced protein glycation, DNA damage, and apoptosis in pancreatic β-cells. J Physiol Biochem 2016; 73:121-131. [PMID: 27822918 DOI: 10.1007/s13105-016-0531-3] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2016] [Accepted: 10/17/2016] [Indexed: 10/20/2022]
Abstract
Methylglyoxal (MG) can react with amino acids of proteins to induce protein glycation and consequently the formation of advanced glycation end-products (AGEs). Previous studies reported that ferulic acid (FA) prevented glucose-, fructose-, and ribose-induced protein glycation. In this study, FA (0.1-1 mM) inhibited MG-induced protein glycation and oxidative protein damage in bovine serum albumin (BSA). Furthermore, FA (0.0125-0.2 mM) protected against lysine/MG-mediated oxidative DNA damage, thereby inhibiting superoxide anion and hydroxyl radical generation during lysine and MG reaction. In addition, FA did not have the ability to trap MG. Finally, FA (0.1 mM) pretreatment attenuated MG-induced decrease in cell viability and prevented MG-induced cell apoptosis in pancreatic β-cells. The results suggest that FA is capable of protecting β-cells from MG-induced cell damage during diabetes.
Collapse
|
10
|
Kumagai Y, Nakatani S, Onodera H, Nagatomo A, Nishida N, Matsuura Y, Kobata K, Wada M. Anti-Glycation Effects of Pomegranate (Punica granatum L.) Fruit Extract and Its Components in Vivo and in Vitro. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY 2015; 63:7760-7764. [PMID: 26242637 DOI: 10.1021/acs.jafc.5b02766] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
Accumulation of advanced glycation end products (AGEs) leads to various diseases such as diabetic complications and arteriosclerosis. In this study, we examined the effect of pomegranate fruit extract (PFE) and its constituent polyphenols on AGE formation in vivo and in vitro. PFE, fed with a high-fat and high-sucrose (HFS) diet to KK-A(y) mice, significantly reduced glycation products such as glycoalbumin (22.0 ± 2.4%), hemoglobin A1c (5.84 ± 0.23%), and serum AGEs (8.22 ± 0.17 μg/mL), as compared to a control HFS group (30.6 ± 2.6%, 7.45 ± 0.12%, and 9.55 ± 0.17 μg/mL, respectively, P < 0.05). In antiglycation assays, PFE, punicalin, punicalagin, ellagic acid, and gallic acid suppressed the formation of AGEs from bovine serum albumin and sugars. In this study, we discuss the mechanism of the antiglycation effects of PFE and its components in vivo and in vitro.
Collapse
Affiliation(s)
- Yuya Kumagai
- Department of Pharmaceutial and Health Sciences, Faculty of Pharmaceutical Sciences, Josai University , Saitama, Japan
| | - Sachie Nakatani
- Department of Pharmaceutial and Health Sciences, Faculty of Pharmaceutical Sciences, Josai University , Saitama, Japan
| | - Hideaki Onodera
- Department of Pharmaceutial and Health Sciences, Faculty of Pharmaceutical Sciences, Josai University , Saitama, Japan
| | | | | | | | - Kenji Kobata
- Department of Pharmaceutial and Health Sciences, Faculty of Pharmaceutical Sciences, Josai University , Saitama, Japan
| | - Masahiro Wada
- Department of Pharmaceutial and Health Sciences, Faculty of Pharmaceutical Sciences, Josai University , Saitama, Japan
| |
Collapse
|
11
|
Liu M, Pan Q, Chen Y, Yang X, Zhao B, Jia L, Zhu Y, Zhang B, Gao X, Li X, Han J, Duan Y. Administration of Danhong Injection to diabetic db/db mice inhibits the development of diabetic retinopathy and nephropathy. Sci Rep 2015; 5:11219. [PMID: 26061387 PMCID: PMC4462147 DOI: 10.1038/srep11219] [Citation(s) in RCA: 38] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2015] [Accepted: 05/18/2015] [Indexed: 12/21/2022] Open
Abstract
Danhong Injection (DHI), a Chinese medicine for treatment of patients with coronary heart disease, inhibits primary abdominal aortic aneurysms in apoE deficient (apoE−/−) mice. Formation of microaneurysms plays an important role in the development of diabetic retinopathy and nephropathy. It remains unknown if DHI can reduce these diabetic complications. In this study, diabetic db/db mice in two groups were injected with saline and DHI, respectively, for 14 weeks. Blood and tissue samples were collected to determine serum glucose, lipids and tissue structure. DHI reduced diabetes-induced body weight gain, serum cholesterol and glucose levels. In retinas, DHI blocked the shrink of whole retina and retinal sub-layers by inhibiting expression of caspase 3, matrix metalloproteinase 2 (MMP-2) and MMP-9, accumulation of carbohydrate macromolecules and formation of acellular capillaries. DHI improved renal functions by inhibiting mesangial matrix expansion, expression of vascular endothelial growth factor A, fibronectin and advanced glycation end products in kidneys. Mechanistically, DHI induced expression of glucokinase, AMPKα/phosphorylated AMPKα, insulin receptor substrate 1, fibroblast growth factor 21 and peroxisome proliferator-activated γ. Expression of genes responsible for energy expenditure was also activated by DHI. Therefore, DHI inhibits diabetic retinopathy and nephropathy by ameliorating glucose metabolism and demonstrates a potential application in clinics.
Collapse
Affiliation(s)
- Mengyang Liu
- 1] State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin 300071, China [2] College of Life Sciences, Nankai University, Tianjin 300071, China
| | - Quan Pan
- 1] State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin 300071, China [2] College of Life Sciences, Nankai University, Tianjin 300071, China
| | - Yuanli Chen
- 1] State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin 300071, China [2] Collaborative Innovation Center for Biotherapy, Nankai University, Tianjin 300071, China
| | - Xiaoxiao Yang
- 1] State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin 300071, China [2] College of Life Sciences, Nankai University, Tianjin 300071, China
| | - Buchang Zhao
- Buchang Pharmaceutical Co. Ltd., Xi'an 712000, China
| | - Lifu Jia
- Buchang Pharmaceutical Co. Ltd., Xi'an 712000, China
| | - Yan Zhu
- Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China
| | - Boli Zhang
- Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China
| | - Xiumei Gao
- Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China
| | - Xiaoju Li
- College of Life Sciences, Nankai University, Tianjin 300071, China
| | - Jihong Han
- 1] State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin 300071, China [2] Collaborative Innovation Center for Biotherapy, Nankai University, Tianjin 300071, China
| | - Yajun Duan
- 1] State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin 300071, China [2] Collaborative Innovation Center for Biotherapy, Nankai University, Tianjin 300071, China
| |
Collapse
|
12
|
Chemical and biological properties of quinochalcone C-glycosides from the florets of Carthamus tinctorius. Molecules 2013; 18:15220-54. [PMID: 24335575 PMCID: PMC6270621 DOI: 10.3390/molecules181215220] [Citation(s) in RCA: 67] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2013] [Revised: 12/01/2013] [Accepted: 12/02/2013] [Indexed: 11/24/2022] Open
Abstract
Quinochalcone C-glycosides are regarded as characteristic components that have only been isolated from the florets of Carthamus tinctorius. Recently, quinochalcone C-glycosides were found to have multiple pharmacological activities, which has attracted the attention of many researchers to explore these compounds. This review aims to summarize quinochalcone C-glycosides’ physicochemical properties, chromatographic behavior, spectroscopic characteristics, as well as their biological activities, which will be helpful for further study and development of quinochalcone C-glycosides.
Collapse
|
13
|
Li W, Xu H, Hu Y, He P, Ni Z, Xu H, Zhang Z, Dai H. Edaravone protected human brain microvascular endothelial cells from methylglyoxal-induced injury by inhibiting AGEs/RAGE/oxidative stress. PLoS One 2013; 8:e76025. [PMID: 24098758 PMCID: PMC3786889 DOI: 10.1371/journal.pone.0076025] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2013] [Accepted: 08/23/2013] [Indexed: 01/01/2023] Open
Abstract
Subjects with diabetes experience an increased risk of cerebrovascular disease and stroke compared with nondiabetic age-matched individuals. Increased formation of reactive physiological dicarbonyl compound methylglyoxal (MGO) seems to be implicated in the development of diabetic vascular complication due to its protein glycation and oxidative stress effect. Edaravone, a novel radical scavenger, has been reported to display the advantageous effects on ischemic stroke both in animals and clinical trials; however, little is known about whether edaravone has protective effects on diabetic cerebrovascular injury. Using cultured human brain microvascular endothelial cells (HBMEC), protective effects of edaravone on MGO and MGO enhancing oxygen-glucose deprivation (OGD) induced injury were investigated. Cell injury was measured by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) formation, cell account, lactate dehydrogenase (LDH) release and Rhodamine 123 staining. Advanced glycation end-products (AGEs) formation and receptor for advanced glycation end-products (RAGE) expression were measured by western blotting. Cellular oxidative stress was measured by reactive oxygen species (ROS) release. Treatment of MGO for 24 h significantly induced HBMEC injury, which was inhibited by pretreatment of edaravone from 10–100 µmol/l. What’s more, treatment of MGO enhanced AGEs accumulation, RAGE expression and ROS release in the cultured HBMEC, which were inhibited by 100 µmol/l edaravone. Finally, treatment of MGO for 24 h and then followed by 3 h OGD insult significantly enhanced cell injury when compared with OGD insult only, which was also protected by 100 µmol/l edaravone. Thus, edaravone protected HBMEC from MGO and MGO enhancing OGD-induced injury by inhibiting AGEs/RAGE/oxidative stress.
Collapse
Affiliation(s)
- Wenlu Li
- Department of Pharmacy, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
| | | | | | | | | | | | | | | |
Collapse
|
14
|
Li W, Liu J, He P, Ni Z, Hu Y, Xu H, Dai H. Hydroxysafflor yellow A protects methylglyoxal-induced injury in the cultured human brain microvascular endothelial cells. Neurosci Lett 2013; 549:146-50. [PMID: 23774474 DOI: 10.1016/j.neulet.2013.06.007] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2013] [Revised: 05/15/2013] [Accepted: 06/02/2013] [Indexed: 01/09/2023]
Abstract
Individuals with diabetes have high concentration of methylglyoxal (MGO) and have advanced glycation end-products (AGEs) which play an important role in vascular complications, such as stroke. Our previous data demonstrated that hydroxysafflor yellow A (HSYA), a major active chemical component of the safflower yellow pigment, had antiglycation effect on the AGEs formation in vitro. It is not known whether HSYA can protect against MGO-induced injury in cultured human brain microvascular endothelial cells (HBMEC). Using cultured HBMEC, cell injury was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) formation, lactate dehydrogenase (LDH) release and AnnexinV/PI staining. Advanced glycogen end-products and caspase-3 formation were measured by Western blotting. Incubation of MGO for 24h concentration-dependently induced HBMEC injury, which was protected by HSYA from 10 to 100 μmol/l. Caspase-3 expression and AnnexinV/PI staining illustrated that the protection of HSYA was probably associated with inhibiting cell apoptosis. What's more, MGO promoted AGEs accumulation in the cultured HBMEC, which was also inhibited by 100 μmol/l HSYA. Thus, our results proved that HSYA could inhibit MGO-induced injury in the cultured HBMEC, which was associated with its antiglycation effect.
Collapse
Affiliation(s)
- Wenlu Li
- Department of Pharmacy, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China
| | | | | | | | | | | | | |
Collapse
|